Detection of Epstein-Barr Virus DNA in Langerhans Cell Histiocytosis

被引:5
|
作者
Khoddami, Maliheh [1 ]
Nadji, Seyed Alireza [2 ]
Dehghanian, Paria [3 ]
Vahdatinia, Mahsa [4 ]
Shamshiri, Ahmad Reza [5 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Pathol, Pediat Pathol Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Virol Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Mofid Childrens Hosp, Pediat Infect Dis Res Ctr, Dept Pathol, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Dept Pathol, Tehran, Iran
[5] Univ Tehran Med Sci, Dent Res Inst, Sch Dent, Dept Community Oral Hlth,Dent Res Ctr, Tehran, Iran
关键词
Histiocytosis; Langerhans-Cell; Epstein-Barr Virus Infections; Polymerase Chain Reaction; Dendritic Cells; Cell Proliferation; DENDRITIC CELLS; INFECTION; LYMPHOMA;
D O I
10.5812/jjm.27219
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Langerhans cell histiocytosis (LCH) is a rare histiocytic proliferation of unknown etiology. It is characterized by granuloma-like proliferation of Langerhans-type dendritic cells and mainly affects young children. Although multiple investigators have suggested the possible role of viruses, such as Epstein-Barr virus (EBV), human herpesvirus-6 (HHV-6), Herpes simplex virus (HSV) types 1 and 2, and Cytomegalovirus (CMV) in the pathogenesis of LCH, it remains, however, debated. Objectives: The EBV infection is reported to be associated with LCH. Nevertheless, no report could be found about involved Iranian children in English medical literature. In this study, we investigated the presence of EBV in Iranian children with LCH. Patients and Methods: In this retrospective study, in which we investigated the prevalence of presence of EBV DNA in LCH, using paraffin-embedded tissue samples of 30 patients with LCH and 30 age and tissue-matched controls, who were operated for reasons other than infectious diseases (between the years 2002 and 2012), by real-time polymerase chain reaction (RT-PCR) method, in the department of pediatric pathology. No ethical issues arose in the study, because only the pathology reports were reviewed, retrospectively, and the patients were anonymous. Results: There was a significant difference in prevalence of EBV presence between patients and controls. The EBV was found by RT-PCR in 19 (63.33%) out of 30 patients and only in eight (26.7%) of 30 control samples. The P = 0.004, was calculated using chi-square test (OR: 4.75; 95% CI: 1.58. 14.25). Conclusions: Our study is the first investigation performed on patients with LCH and its possible association with EBV in Iran. Considering the P = 0.004, which is statistically significant, the findings do support the hypothesis of a possible role for EBV in the pathogenesis of LCH. These results are in accordance with several previous investigations, with positive findings.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [31] THE DNA-SEQUENCE OF EPSTEIN-BARR VIRUS
    不详
    LANCET, 1984, 2 (8398): : 327 - 328
  • [32] Detection of Epstein-Barr virus DNA in gastric carcinoma with lymphoid stroma
    Jing, XF
    Nakamura, Y
    Nakamura, M
    Yokoi, T
    Shan, L
    Taniguchi, E
    Kakudo, K
    VIRAL IMMUNOLOGY, 1997, 10 (01) : 49 - 58
  • [33] Plasma Epstein-Barr Virus DNA for Screening
    Ambinder, Richard F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (06): : 584 - 585
  • [34] Viral DNA contamination is responsible for Epstein-Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein-Barr virus B-lymphoblastoid cell line
    Berthome, Mathilde
    Gallot, Geraldine
    Vivien, Regine
    Clemenceau, Beatrice
    Nguyen, Jean-Michel
    Coste-Burel, Marianne
    Vie, Henri
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (12) : 1867 - 1875
  • [35] Epstein-Barr virus DNA in body fluids
    Lechowicz, MJ
    Lin, L
    Ambinder, RF
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (05) : 533 - 537
  • [36] Epstein-Barr Virus-Positive Langerhans Cell Sarcoma: Is There a Link? A Case Report
    Guo, Yu
    Zhou, Shui-Hong
    Cao, Zai-Zai
    Bao, Yang-Yang
    Shen, Li-Fang
    Yao, Hong-Tian
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [37] DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma
    Choi, Su Jin
    Shin, Yu Su
    Kang, Byung Woog
    Kim, Jong Gwang
    Won, Kyoung-Jae
    Lieberman, Paul M.
    Cho, Hyosun
    Kang, Hyojeung
    ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (08) : 894 - 905
  • [38] Detection of cell free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma
    Hsiao, JR
    Jin, YT
    Tsai, ST
    CANCER, 2002, 94 (03) : 723 - 729
  • [39] Plasma Epstein-Barr Virus DNA load for diagnostic and prognostic assessment in intestinal Epstein-Barr Virus infection
    Ma, Chunxiang
    Jiang, Mingshan
    Li, Jiaxin
    Zeng, Zhen
    Wu, Yushan
    Cheng, Rui
    Lin, Hao
    Pang, Jiangmei
    Yin, Fang
    Jia, Yongbin
    Li, Lili
    Zhang, Hu
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2025, 14
  • [40] Evaluation of plasma Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-associated Hodgkin lymphoma
    Usha, Masuma Khatun
    Jahan, Jasmine Akhter
    Ul Islam, Sm Rashed
    Begum, Ferdousy
    Ahsan, Chowdhury Rafiqul
    Yasmin, Mahmuda
    SAGE OPEN MEDICINE, 2021, 9